Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ:ATRA). Investors who purchased Atara ...

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ:ATRA). Investors who purchased Atara ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Join us Feb. 26 for a free webinar to get practical tips on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Contrary to popular opinion, Linux is an operating system that can be used and enjoyed by everyone and anyone. I mean, I taught my then-mother-in-law at the age of 79 how to use Ubuntu Linux ...

A good ZZZ Astra Yao build is easy to put together, even if you don’t have the support singer’s signature W-Engine. Astra Yao needs just two stats, and she works with almost any party combination.

But the visual representation of this industry disruptor is not a swirling black-void logo à la OpenAI, or even a robot. Instead, it’s a friendly blue whale. This diverges from branding trends ...

We went hands-on with some of the best laptops on the market that can run Linux, testing their performance, battery, and features. Our pick for the best Linux laptop overall is the Lenovo ThinkPad ...

Building the best Astra Yao teams is essential to unlocking the full potential of Zenless Zone Zero‘s first healer agent. Introduced in version 1.5, Astra Yao is a renowned singer and actress, ...

Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo.